Skip to main content
Yantai Zhenghai Bio-Tech Co., Ltd. logo

Yantai Zhenghai Bio-Tech Co., Ltd. — Investor Relations & Filings

Ticker · 300653 ISIN · CNE100002NZ1 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 969 across all filing types
Latest filing 2024-02-02 Transaction in Own Shar…
Country CN China
Listing Shenzhen Stock Exchange 300653

About Yantai Zhenghai Bio-Tech Co., Ltd.

https://www.zhbio.com

Yantai Zhenghai Bio-Tech Co., Ltd. specializes in the research, development, production, and sale of regenerative medicine materials. The company focuses on tissue engineering and biomaterials to provide solutions for clinical repair and functional reconstruction. Its core product portfolio includes the Heal-All oral repair membrane, absorbable hard cerebral (spinal) membrane patches, and skin repair membranes. These products are widely utilized in stomatology, neurosurgery, and orthopedics. The company leverages advanced processing technologies to ensure biocompatibility and safety in its medical devices. By integrating research with clinical needs, it develops innovative bone repair materials and other biological scaffolds designed to facilitate natural tissue regeneration.

Recent filings

Filing Released Lang Actions
关于回购股份的进展公告
Transaction in Own Shares Classification · 100% confidence The document is titled '关于回购股份的进展公告' which translates to 'Announcement on the Progress of Share Repurchase'. It details the company's plan and progress regarding the repurchase of its own shares, including the amount, price limits, and regulatory compliance. It explicitly states the progress as of a certain date and references previous announcements about the repurchase plan. The document is short (1135 characters) and focuses on the update of the share buyback activity rather than presenting financial statements or detailed financial data. This fits the definition of a 'Transaction in Own Shares' (POS) filing, which covers reports of the company buying back or selling its own shares (share repurchase/issuance).
2024-02-02 Chinese
关于使用闲置自有资金进行现金管理的进展公告
Regulatory Filings Classification · 95% confidence The document is titled '现金管理进展公告' which translates to 'Cash Management Progress Announcement'. It details the company's use of idle funds for cash management, including specific financial products purchased, amounts, dates, expected yields, risk control measures, and impact on the company. The document is an announcement of the progress and status of cash management activities rather than a full financial report or earnings release. It does not contain comprehensive financial statements or detailed financial analysis typical of Annual Reports (10-K), Interim Reports (IR), or Earnings Releases (ER). It also does not fit into categories like Capital/Financing Update (CAP) or Regulatory Filings (RNS) since it is a specific progress announcement about cash management activities. Given the content and length (5330 characters), it is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement about cash management progress that does not fit other more specific categories.
2024-01-18 Chinese
关于回购股份的进展公告
Transaction in Own Shares Classification · 100% confidence The document is titled '关于回购股份的进展公告' which translates to 'Announcement on the Progress of Share Repurchase'. It details the company's board approval of a share repurchase plan, the intended amount and price limits, and the progress status as of a certain date, stating that no shares have been repurchased yet. The document references regulatory rules on share repurchases and states it is an update on the progress of the repurchase plan. The document length is short (1136 characters) and it is clearly an announcement of progress rather than a full report or financial statement. This fits the definition of a 'Transaction in Own Shares' (POS) filing, which covers reports of the company buying back or selling its own shares. Therefore, the correct classification is POS with high confidence.
2024-01-03 Chinese
关于回购股份事项前十名股东及前十名无限售条件股东持股情况的公告
Transaction in Own Shares Classification · 100% confidence The document is an announcement from Yantai Zhenghai Biotechnology Co., Ltd. regarding the top ten shareholders and top ten unrestricted shareholders as of a specific date (December 19, 2023) in relation to a share repurchase plan approved on December 20, 2023. It includes detailed shareholding information and references regulatory rules about share repurchase. The document is not a financial report, earnings release, or management discussion, but a formal disclosure about shareholding status connected to a share buyback. This fits the category of Transaction in Own Shares (POS), which covers company announcements about share repurchases or sales of own shares.
2023-12-26 Chinese
回购报告书
Transaction in Own Shares Classification · 100% confidence The document is titled '回购报告书' which translates to 'Repurchase Report' or 'Buyback Report'. It details the company's plan to repurchase its own shares using its own funds, including the purpose, amount, price range, implementation period, and regulatory compliance. The document includes specifics about the number of shares to be repurchased, the funding source, authorization, and risk disclosures. It is a comprehensive disclosure about the company's share buyback program rather than a brief announcement or a financial report. The content aligns with the definition of 'Transaction in Own Shares' (POS), which covers reports of the company buying back its own shares. The document length (7841 characters) and detailed content confirm it is the report itself, not just an announcement or a certification. Therefore, the correct classification is POS with high confidence.
2023-12-26 Chinese
第三届监事会第十二次会议决议公告
Transaction in Own Shares Classification · 95% confidence The document is titled '监事会决议公告' which translates to 'Supervisory Board Resolution Announcement'. It details the resolution passed by the supervisory board regarding a share repurchase plan, including specifics on price, amount, and purpose. The document is an announcement of a board resolution rather than a full report or financial statement. It is short (1300 characters) and serves to inform about the supervisory board's decision on share repurchase. This fits the category of Transaction in Own Shares (POS), which covers announcements of company buybacks or sales of its own shares.
2023-12-20 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.